Astrana Health (ASTH) Stock Could Be 8.8% Overvalued After Strong Results

Simply Wall St.06-19

AdvertisementAstrana Health event: shelf registration follows strong operating performance Astrana Health (ASTH) recently filed a shelf registration for up to 1,000,000 common shares, tied to an ESOP ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2644057047?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-06-19 22:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644057047","market":"hk","top_or_hot":-1,"title":"Astrana Health (ASTH) Stock Could Be 8.8% Overvalued After Strong Results","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementAstrana Health event: shelf registration follows strong operating performance Astrana Health (ASTH) recently filed a shelf registration for up to 1,000,000 common shares, tied to an ESOP ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/astrana-health-asth-stock-could-be-88-overvalued-after-stron\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Astrana Health (ASTH) Stock Could Be 8.8% Overvalued After Strong Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstrana Health (ASTH) Stock Could Be 8.8% Overvalued After Strong Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-19 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/astrana-health-asth-stock-could-be-88-overvalued-after-stron><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementAstrana Health event: shelf registration follows strong operating performance Astrana Health (ASTH) recently filed a shelf registration for up to 1,000,000 common shares, tied to an ESOP ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/astrana-health-asth-stock-could-be-88-overvalued-after-stron\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/astrana-health-asth-stock-could-be-88-overvalued-after-stron","article_id":"2644057047","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-asth/astrana-health/news/astrana-health-asth-stock-could-be-88-overvalued-after-stron","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2644057047","pubTimestamp":1781878788,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Astrana Health event: shelf registration follows strong operating performance\nAstrana Health (ASTH) recently filed a shelf registration for up to 1,000,000 common shares, tied to an ESOP related offering, shortly after reporting operating efficiency and financial metrics that highlight its current business momentum.\nSee our latest analysis for Astrana Health.\nThe latest shelf registration comes at a time when Astrana Health’s share price has gained 61.66% over the past 90 days and its 1 year...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","ASTH":"Astrana Health"},"translate_title":"Astrana Health(ASTH)股票在强劲业绩后可能被高估8.8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"ASTH":1.5},"content_text":"AdvertisementAstrana Health event: shelf registration follows strong operating performance Astrana Health (ASTH) recently filed a shelf registration for up to 1,000,000 common shares, tied to an ESOP related offering, shortly after reporting operating efficiency and financial metrics that highlight its current business momentum. See our latest analysis for Astrana Health. The latest shelf registration comes at a time when Astrana Health’s share price has gained 61.66% over the past 90 days and its 1 year total shareholder return sits at 61.46%, as investors react to stronger operating metrics and robust financial scores. If Astrana Health’s recent run has you looking for other healthcare ideas tied to technology and data, it could be worth scanning for more opportunities via 41 healthcare AI stocks. With Astrana Health’s shares up sharply over the past year, a strong financial score of 9.45 and revenue and net income growth in place, the key question is whether there is still a buying opportunity or if markets are already pricing in future growth. Most Popular Narrative: 8.8% Overvalued Astrana Health’s most followed narrative points to a fair value of $36 against a last close of $39.17, so the debate is about how much of the value based care story is already reflected in the price.  Long term tailwinds from regulatory and payer shifts towards alternative payment models and value based healthcare are expanding the addressable market and favor operators with mature, risk bearing platforms like Astrana, setting the stage for durable revenue and profit growth as national healthcare expenditure rises.  Read the complete narrative. Want the full picture behind that $36 figure? The narrative leans heavily on compound earnings, measured revenue gains and a meaningfully different profit margin profile. Curious which assumptions really carry the model? Result: Fair Value of $36 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, Astrana Health’s setup still carries execution and policy risk, particularly around government reimbursement exposure and the challenge of integrating larger acquisitions cleanly. Find out about the key risks to this Astrana Health narrative. Another View on Astrana Health’s Valuation The narrative fair value of $36 suggests Astrana Health is 8.8% overvalued, but the SWS DCF model points in the opposite direction, with a future cash flow value estimate of $117.80 per share. That is a very large gap. Which story do you trust more? Look into how the SWS DCF model arrives at its fair value. ASTH Discounted Cash Flow as at Jun 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Astrana Health for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 45 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps After weighing Astrana Health’s narratives, valuation models and recent share price move, it helps to see the underlying drivers for yourself and decide quickly what really matters. To balance the concerns and potential upside, review the 2 key rewards and 3 important warning signs. Looking for more investment ideas beyond Astrana Health? If Astrana Health has sharpened your focus on where capital goes next, do not stop here. Fresh ideas from other high potential stocks could reshape your portfolio.  Target quality at a discount by scanning companies with strong fundamentals using the 45 high quality undervalued stocks. Strengthen your income stream by reviewing companies screened for robust payouts via the 8 dividend fortresses. Dial down risk without stepping away from opportunities by assessing companies filtered through the 66 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644057047","isCrawlerRequest":true}